SENS.L Regulatory News (SENS)

Annual Report and Accounts and Notice of Annual General Meeting

Oxford, U.K. 06 October 2020: Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the UK Clinical AI company, announces that its Annual Report and Accounts for the year ended 30 April 2020 is now available on the Group's website at https://www.sensynehealth.com/investors/investor-hub 

Copies of the Annual Report and Accounts will be posted later today to those shareholders that have elected to receive paper communications.

The Company also announces that its Notice of Annual General Meeting has been posted to shareholders today. The Annual General Meeting will be held virtually on 30 October 2020 at 1400 GMT.

As a result of current public health advice and "Stay at Home" guidance, the Company wishes to notify its shareholders that physical attendance in person at the AGM will not be possible.

-ENDS-

For more information please contact:

About Sensyne Health 

Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L).

For more information, please visit: www.sensynehealth.com